期刊文献+

纳米仿生型肿瘤疫苗的研究进展 被引量:1

Advances in the study of nano-biomimetic tumor vaccines
原文传递
导出
摘要 肿瘤疫苗作为肿瘤免疫疗法的一种,为癌症治疗提供了新策略。利用纳米仿生材料包被肿瘤抗原,构建纳米仿生型肿瘤疫苗,可实现抗原的靶向递释,具有高效性和安全性等优点。因此,纳米仿生型疫苗成为当今的研究热点。据此,本文综述了新型纳米仿生肿瘤疫苗的研究进展,并介绍了其临床应用及同其他疗法的联合应用情况。 As a kind of tumor immunotherapy, tumor vaccine provides a new strategy for cancer treatment.With nano-biomimetic materials to encapsulate the tumor antigens, the construction of nano-biomimetic tumor vaccine can target the tumor and release antigens, with high efficiency and safety. Therefore, nano-biomimetic vaccine has become a hot research topic. Based on this review, several new nano-biomimetic nanoparticles are summarized, and the clinical applications of the nano-biomimetic vaccine combined with other therapeutic strategies are introduced.
作者 杨玥 王海燕 孙野 孙涛 蒋晨 YANG Yue;WANG Hai-yan;SUN Ye;SUN Tao;JIANG Chen(Key Laboratory of Smart Drug Delivery(Ministry of Education),Minhang Hospital,State Key Laboratory of Medical Neurobiology,Department of Pharmaceutics,School of Pharmacy,Fudan University,Shanghai 201203)
机构地区 复旦大学药学院
出处 《药学学报》 CAS CSCD 北大核心 2022年第4期963-975,共13页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(92059110,81872808) 上海人才发展资金项目(2020090) 复旦大学2025卓学计划(to T.S.) 上海学科带头人计划(2018SHZDZX01) 复旦大学-中国科学院上海药物研究所融合基金项目(FU-SIMM-20182006)。
关键词 肿瘤疫苗 免疫治疗 纳米仿生型材料 免疫佐剂 药物靶向递送 tumor vaccine immunotherapy nano-biomimetic material immune adjuvant targeting drug delivery
  • 相关文献

参考文献8

二级参考文献41

  • 1Zhijian Luo,Yan Dai,Huile Gao.Development and application of hyaluronic acid in tumor targeting drug delivery[J].Acta Pharmaceutica Sinica B,2019,9(6):1099-1112. 被引量:15
  • 2Xiaofei Xin,Xiaoqing Du,Qingqing Xiao,Helena SAzevedo,Wei He,Lifang Yin.Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition[J].Nano-Micro Letters,2019,11(4):453-468. 被引量:6
  • 3世界卫生组织:制止慢性病的全球流行.http://www.who.int/mediacentre/news/releases/2005/pr47/zh/index.html.
  • 4Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol, 2007, 81 : 1 - 5.
  • 5Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock, 2006, 25 : 571-574.
  • 6Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med, 2007, 204 : 2913 -2923.
  • 7Hamada N, Maeyama T, Kawaguchi T, et al. The Role of High Mobility Group boxl in Pulmonary Fibrosis. Am J Respir Cell Mol Biol, 2008, 39 : 440 -447.
  • 8Vabulas RM, Ahmad-Nejad P, Ghose S, et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem, 2002, 277 : 15107 - 15112.
  • 9Ohno M, Kitabatake N, Tani F. Functional region of mouse heat shock protein 72 for its binding to lymphoid neoplastic P388D1 cells. Mol Immunol, 2007, 44 : 2344 -2354.
  • 10Foell D, Frosch M, Sorg C, et al. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta, 2004, 344 : 37 -51.

共引文献46

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部